The Neuropsychiatry Unit has been under development since the end of 2012 as an interface between the Clinical Centre and the Neuroscience Programme. We intend to be an established clinical excellence centre for diagnosis and treatment in mental and behavioural health, focusing on specific intervention areas that are contiguous with the neuroscience research that is performed at the Champalimaud Foundation. Thus, the Unit is made up both of physicians and other clinical professionals who also work in the Neuroscience Programme, as well as researchers who are devoted to deepening our knowledge of neuropsychiatric disorders. Together, they are particularly dedicated to treating patients who suffer from problems within the Obsessive Compulsive Disorder (OCD) spectrum.
The multidisciplinary team that provides clinical care for these patients is made up of physicians from the area of Psychiatry and Mental Health, and neuropsychologists, working in close collaboration with nuclear medicine specialists, neuroradiologists and nurses. This team ensures a high degree of precision in diagnosis, as well as rigorous definition of treatment according to standard international guidelines. Additionally, the Unit has developed close collaborations with other international centres that are devoted to developing new approaches for the treatment of these disorders. This will allow patients who are resistant to conventional treatment to have access to novel, experimental, therapeutic approaches.
The Unit’s clinical staff, collaborators and researchers are also dedicated to scientific and clinical research on OCD spectrum disorders. The main goal of these research projects, that are also developed in the context of the clinical activity of the Unit, is to allow for a better diagnostic and neurobiological description of these disorders, as well as to perform research on novel therapeutic alternatives, both pharmacologic or using neurostimulation. The close contact between clinical and research activities promotes excellence in the clinical care delivered to patients at our unit, possibly also allowing for significant advances in the knowledge about these disorders.